NPPB and Huntington disease: In this study, we evaluated, for the first time, the prognostic potential of major cardiovascular markers, high-sensitivity cTnI (hs-cTnI), NT-proBNP, and adiponectin, for ACM and CVM in stable HD patients over a long follow-up period of 7 years.